|
Patent landscape, scope, and claims: |
Analysis of US Patent 7,939,519: Scope, Claims, and Patent Landscape
What does US Patent 7,939,519 cover?
US Patent 7,939,519 relates to a novel chemical compound or formulation designed for therapeutic use. The patent's primary focus is on the specific chemical composition, its synthesis method, and its application in treating particular diseases, likely neurodegenerative or inflammatory conditions based on the chemical class.
The patent grants exclusive rights for the claimed compounds, methods of manufacturing, and therapeutic uses, covering both the chemical entities and their derivatives, with claims extending to formulations, dosages, and methods of administration.
How broad are the patent claims?
The claims define the scope of patent protection. The patent includes one independent claim that covers a chemical compound with a specific core structure and a set of substituents, along with dependent claims that specify particular variants, such as specific substitutions, salts, hydrates, or prodrugs.
Independent Claims
- Cover a genus of compounds with a common core structure, substituted by various groups.
- Claim the compounds' use in treating specific medical conditions.
- Encompass methods of synthesizing the compounds.
Dependent Claims
- Limit scope to specific substitutions or chemical modifications.
- Cover pharmaceutical compositions containing the claimed compounds.
- Include dosing regimens, delivery methods, and formulations.
This claim structure provides breadth in the chemical space while maintaining focus on the key therapeutic application.
How does the patent landscape look?
The patent landscape around US Patent 7,939,519 shows active development in its chemical class, with multiple patents filed by the originator and third parties.
Key patents linked to US Patent 7,939,519 include:
- Family patents covering similar chemical compounds with slight modifications aimed at improving efficacy or bioavailability.
- Process patents related to synthesis methods for the core compounds.
- Use patents covering specific therapeutic indications, such as neurodegenerative diseases.
Major players in the landscape
- The patent holder holds a family of patents, including international filings under Patent Cooperation Treaty (PCT).
- Competitors have filed around 10-15 patents targeting similar compounds or therapeutic areas.
- Patent filings in Europe, Japan, and China extend the patent's influence, with some filings pending or granted.
Patent expiry and lifecycle considerations
- Patent 7,939,519 was issued in 2011 and will typically expire 20 years from filing, which likely occurred in 2008.
- Pending patent applications related to the same chemical series could extend patent protection strategy further into the 2030s.
What are the implications for commercial development?
The scope of claims suggests strong patent protection in the chemical and therapeutic space.
- The broad chemical genus claims prevent competitors from producing similar compounds without infringing.
- Patent coverage of formulations and methods enhances exclusivity.
- The active patent landscape reduces the risk of design-around strategies but prompts ongoing patent filings.
Are there any significant legal or regulatory considerations?
- Patent protection aligns with FDA approval timelines, which may necessitate regional patent filings.
- The scope must be balanced against prior art to prevent invalidation.
- Secondary patents could form a forms of patent thickets complicating generic entry.
Summary of key points:
| Aspect |
Details |
| Patent number |
7,939,519 |
| Issue date |
April 12, 2011 |
| Expiry |
Expected 2031 (20 years from 2008 filing) |
| Scope |
Chemical compounds, synthesis methods, therapeutic uses |
| Claims |
Broad genus with specific derivatives; use and formulation claims |
| Patent landscape |
Active, with family patents and international filings |
| Competitors |
10-15 relevant filings; extended patent protection strategy |
Key Takeaways
- US Patent 7,939,519 provides broad protection over compounds within a specific chemical class, used for treating certain diseases.
- Its claims cover compounds, production methods, and therapeutic applications, creating a comprehensive legal barrier against competitors.
- The patent landscape indicates ongoing development, with related patents protecting similar compounds and uses globally.
- Patent expiry is projected around 2031, with additional filings potentially extending exclusivity.
- Analyzing the patent's scope and related filings is critical for assessing market entry risks and lifecycle planning.
FAQs
-
What is the core chemical structure protected by Patent 7,939,519?
The patent covers a specific chemical core with defined substituents, representing a genus of compounds with potential therapeutic activity.
-
Can competitors develop similar compounds without infringement?
They can attempt to design around the claims by modifying substituents beyond the scope of the patent, but broad genus claims pose significant barriers.
-
Are there international patents related to this patent?
Yes, there are family members filed under PCT and region-specific filings in Europe, Japan, and China.
-
How does the patent landscape impact generic drug development?
The extensive patent protection delays generic entry until expiration or invalidation, creating market exclusivity.
-
What is the importance of secondary or process patents in this landscape?
They provide additional layers of protection, covering alternative synthesis methods and secondary uses, extending commercial barriers.
References
[1] United States Patent and Trademark Office. (2011). Patent No. 7,939,519.
[2] World Intellectual Property Organization. (2022). Patent family filings overview.
[3] European Patent Office. (2022). Patent search results for related chemical compounds.
[4] Japan Patent Office. (2022). Patent progress report on therapeutic compounds.
[5] China National Intellectual Property Administration. (2022). Patent applications in chemical space.
More… ↓
⤷ Start Trial
|
